This HTML5 document contains 13 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
n8http://www.medimmune.com/
n7http://en.wikipedia.org/wiki/Special:FilePath/MedImmune_logo.gif?width=
n5http://en.wikipedia.org/wiki/Special:FilePath/MedImmune_logo.
dbpedia-owlhttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n6http://dbpedia.org/resource/Gaithersburg,
rdfshttp://www.w3.org/2000/01/rdf-schema#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
dbpediahttp://dbpedia.org/resource/
Subject Item
dbpedia:MedImmune
rdfs:comment
MedImmune, LLC, headquartered in Gaithersburg, Maryland, became a wholly owned subsidiary of AstraZeneca in 2007. Since being acquired, MedImmune has remained a Maryland-based biotechnology development enterprise. It produces Synagis, a drug for the prevention of respiratory infections in infants, which accounted for US$ 1.06 billion of its US$ 1.2 billion in revenue for 2005, and FluMist, a nasal spray influenza vaccine introduced in 2004.
foaf:name
MedImmune, LLC
foaf:homepage
n8:
foaf:depiction
n5:gif
dbpedia-owl:industry
dbpedia:Pharmaceutical_industry
dbpedia-owl:location
n6:_Maryland dbpedia:Maryland dbpedia:United_States
dbpedia-owl:parentCompany
dbpedia:AstraZeneca
dbpedia-owl:product
dbpedia:Palivizumab dbpedia:Live_attenuated_influenza_vaccine
dbpedia-owl:thumbnail
n7:300
dbpedia-owl:type
dbpedia:Subsidiary